Pages that link to "Q33346465"
Jump to navigation
Jump to search
The following pages link to Human Papillomavirus type distribution in invasive cervical cancer in Uganda (Q33346465):
Displaying 24 items.
- Are the currently existing anti-human papillomavirus vaccines appropriate for the developing world? (Q27692056) (← links)
- The association between HIV infection, antiretroviral therapy and cervical squamous intraepithelial lesions in South Western Nigerian women (Q28538637) (← links)
- The usefulness of immunohistochemistry in tissue microarrays of Human Papillomavirus negative adenocarcinoma of the uterine cervix (Q30978718) (← links)
- Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers (Q33526682) (← links)
- Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study (Q33759625) (← links)
- Update on prevention and screening of cervical cancer (Q34031269) (← links)
- The burden of human papillomavirus infections and related diseases in sub-saharan Africa (Q34089781) (← links)
- Comparison of human papillomavirus detection between freshly frozen tissue and paraffin embedded tissue of invasive cervical cancer (Q34198635) (← links)
- Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review (Q35185950) (← links)
- Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis (Q35413976) (← links)
- Detection, genotyping and quantitation of multiple hpv infections in south African women with cervical squamous cell carcinoma (Q35650525) (← links)
- Acceptability of study procedures (self-collected introital swabs, blood draws and stool sample collection) by students 10-16 years for an HPV vaccine effectiveness study: a pilot study (Q35958294) (← links)
- Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda (Q36092294) (← links)
- Potential benefits of second-generation human papillomavirus vaccines (Q36380862) (← links)
- Improvement of DNA extraction for human papillomavirus genotyping from formalin-fixed paraffin-embedded tissues. (Q36574450) (← links)
- Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage (Q37011809) (← links)
- Cervical cancer: the sub-Saharan African perspective (Q37332707) (← links)
- Human Papillomavirus types distribution among women with cervical preneoplastic, lesions and cancer in Luanda, Angola (Q37608182) (← links)
- Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences? (Q38866908) (← links)
- Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation. (Q38873428) (← links)
- Human papillomavirus genotypes distribution by cervical cytologic status among women attending the General Hospital of Loandjili, Pointe-Noire, Southwest Congo (Brazzaville). (Q39008298) (← links)
- Genotypic characterisation of human papillomavirus infections among persons living with HIV infection; a case-control study in Kumasi, Ghana (Q39614507) (← links)
- Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa (Q42277972) (← links)
- Prospective evaluation of E6/E7 mRNA detection by the NucliSENS Easy Q HPV assay in a stepwise protocol (Q42278781) (← links)